Amyloid Beta Peptide Is Released during Thrombosis in the Skin
Open Access
- 8 June 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (6) , 1705
Abstract
While it is known that amyloid beta (Aβ) deposits are found in different tissues of both Alzheimer’s disease (AD) patients and healthy individuals, there remain questions about the physiological role of these deposits, the origin of the Aβ peptide, and the mechanisms of its localization to the tissues. Using immunostaining with specific antibodies, as well as enzyme-linked immunosorbent assay, this study demonstrated Aβ40 peptide accumulation in the skin during local experimental photothrombosis in mice. Specifically, Aβ peptide accumulation was concentrated near the dermal blood vessels in thrombotic skin. It was also studied whether the released peptide affects microorganisms. Application of Aβ40 (4 µM) to the external membrane of yeast cells significantly increased membrane conductance with no visible effect on mouse host cells. The results suggest that Aβ release in the skin is related to skin injury and thrombosis, and occurs along with clotting whenever skin is damaged. These results support the proposition that Aβ release during thrombosis serves as part of a natural defense against infection.Keywords
Funding Information
- National Institutes of Health (1SC1GM122691, 5SC2GM111149)
This publication has 87 references indexed in Scilit:
- Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterizationPeerJ, 2013
- Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibodyMolecular Neurodegeneration, 2012
- Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cellsNeuroReport, 2010
- Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating PropertyPLOS ONE, 2010
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial PeptidePLOS ONE, 2010
- Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigmBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- β-Sheet Structured β-Amyloid(1-40) Perturbs Phosphatidylcholine Model MembranesJournal of Molecular Biology, 2007
- Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in PlasmaBiochemical and Biophysical Research Communications, 2000
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993